The VAMPIRE (Vacuum Aspiration Thrombus Removal) trial showed a trend toward lower incidence of no-reflow and a significantly higher rate of myocardial blush grade 3 in patients treated with thrombus aspiration compared with standard primary PCI 11 .
← all excerpts
Optical coherence tomography assessment of efficacy of thrombus aspiration in patients undergoing a primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
1
—
—